JAMP IMATINIB
Identification of Jamp Imatinib
| No description |
Google image searchProduct monograph
Active ingredient
imatinib (imatinib mesylate), 400 MG
DIN: 02495074
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 27-APR-2021
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
- L01EA — BCR-ABL tyrosine kinase inhibitors (ATC, ATC/DDD)
- L01EA01 — IMATINIB (ATC/DDD)
Reference brand drug: Gleevec
